首页> 美国卫生研究院文献>Virology Journal >Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis

【2h】

Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis

机译：从头开始拉米夫定联合阿德福韦酯联合恩替卡韦单药治疗初治慢性乙型肝炎的疗效和耐药性：一项荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundCurrently, there is no consensus on the efficacy and resistance of de novo combination therapy versus monotherapy for treatment naive patients of chronic hepatitis B (CHB).

机译：背景技术目前，对于从零开始治疗慢性乙型肝炎（CHB）的患者，从头联合疗法与单一疗法的疗效和耐药性尚无共识。

著录项

期刊名称 Virology Journal
作者
Fen Liu; Xiwei Wang; Fang Wei; Huaidong Hu; Dazhi Zhang; Peng Hu; Hong Ren;
展开▼
作者单位

展开▼
年(卷),期 2014(11),-1
年度 2014
页码 59
总页数 11
原文格式 PDF
正文语种
中图分类人体病毒学（致病病毒）;病毒（滤过性病毒）;
关键词
Adefovir dipivoxil Combination De novo Entecavir Lamivudine Naive;

机译：阿德福韦酯;联合用药;从头开始;恩替卡韦;拉米夫定;天真;

相似文献

外文文献
中文文献
专利

1. Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis [J] . Fen Liu, Xiwei Wang, Fang Wei, Virology Journal . 2014,第1期

机译：从头开始拉米夫定联合阿德福韦酯联合恩替卡韦单药治疗初治慢性乙型肝炎的疗效和耐药性：一项荟萃分析
2. Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis [J] . Fen Liu, Xiwei Wang, Fang Wei, Virology Journal . 2014,第1期

机译：从头开始拉米夫定联合阿德福韦酯联合恩替卡韦单药治疗初治慢性乙型肝炎的疗效和耐药性：一项荟萃分析
3. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil [J] . LuJ.-J., LiuK., MaY.-J., Journal of viral hepatitis. . 2013,第Suppla1期

机译：替比夫定联合阿德福韦酯联合恩替卡韦单药治疗HBeAg阳性慢性乙型肝炎对阿德福韦酯耐药的疗效和安全性
4. Adefovir dipivoxil for the treatment of chronic hepatitis B infection and in vitro evaluation of hte cross-resistance profiles of lamivudine,famciclovir and adefovir [C] . X Xiong, A Murray, H Yang, Second workshop related to HIV/AIDS in China . 1999

机译：阿德福韦酯对慢性乙型肝炎感染的治疗以及拉米夫定，泛昔洛韦和阿德福韦的交叉耐药性的体外评估
5. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
6. Optimized combination therapies with adefovir dipivoxil (ADV) and lamivudine telbivudine or entecavir may be effective for chronic hepatitis B patients with a suboptimal response to ADV monotherapy [O] . Xiangyong Li, Yusheng Jie, Xu You, 2015

机译：优化的联合用阿德福韦酯（ADV）和拉米夫定替比夫定或恩替卡韦的联合疗法可能对慢性乙型肝炎患者有效对ADV单一疗法的反应不佳
7. Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis [O] . 2014

机译：从头开始拉米夫定联合阿德福韦酯联合恩替卡韦单药治疗初治慢性乙型肝炎的疗效和耐药性：一项荟萃分析

Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis

摘要

著录项

相似文献

相关主题

期刊订阅